Literature DB >> 3477814

Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.

F V Chisari1, P Filippi, J Buras, A McLachlan, H Popper, C A Pinkert, R D Palmiter, R L Brinster.   

Abstract

Overproduction of the hepatitis B virus (HBV) large envelope polypeptide by transgenic mice containing the entire HBV envelope coding region leads to the formation of extremely long (up to 800 nm), occasionally branching, filamentous 22-nm-diameter hepatitis B surface antigen particles that accumulate within the endoplasmic reticulum of the hepatocyte and are not efficiently secreted. As the endoplasmic reticulum expands to accommodate the increasing cellular filament stores, the hepatocytes become enlarged, hydropic, and eosinophilic and also display the characteristic features of "ground-glass" cells. As filament storage progresses, the ground-glass cells undergo coagulative necrosis and the mice develop an age-dependent lesion, whose severity is related to the intracellular concentration of envelope polypeptide, that is characterized by focal hepatocellular degeneration and necrosis, lobular macrophagic inflammation, and increased serum transaminase activity. Advanced lesions demonstrate hepatocellular hyperplasia evident as lobular architectural disarray and microscopic hepatocellular nodules, many of which no longer contain detectable HBV envelope antigens. These changes may become extreme, producing a massively enlarged liver due to multifocal nodular regenerative hyperplasia. Overproduction of the large HBV envelope polypeptide exerts major structural constraints on HBV particle formation, leading to reduced secretion and progressive intracellular accumulation of hepatitis B surface antigen, which can reach sufficiently high concentrations to be directly cytotoxic to hepatocytes in this transgenic mouse system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3477814      PMCID: PMC299194          DOI: 10.1073/pnas.84.19.6909

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Hepatitis B antigen: nature and distribution of cytoplasmic antigen in hepatocytes of carriers.

Authors:  M A Gerber; S Hadziyannis; C Vissoulis; F Schaffner; F Paronetto; H Popper
Journal:  Proc Soc Exp Biol Med       Date:  1974-03

2.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

3.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

4.  Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes.

Authors:  M A Gerber; S Hadziyannis; C Vissoulis; F Schaffner; F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1974-06       Impact factor: 4.307

5.  Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers.

Authors:  O Stein; M Fainaru; Y Stein
Journal:  Lab Invest       Date:  1972-03       Impact factor: 5.662

6.  Victoria blue-nuclear fast red stain for HBs antigen detection in paraffin section.

Authors:  K Tanaka; W Mori; K Suwa
Journal:  Acta Pathol Jpn       Date:  1981-01

Review 7.  Chronic type B hepatitis and the "healthy" HBsAg carrier state.

Authors:  J H Hoofnagle; D A Shafritz; H Popper
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

8.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Morphometric study of hepatocytes containing hepatitis B surface antigen.

Authors:  M L Chen; M A Gerber; S N Thung; J C Thornton; W K Chung
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

10.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

Authors:  F V Chisari; C A Pinkert; D R Milich; P Filippi; A McLachlan; R D Palmiter; R L Brinster
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

View more
  95 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes.

Authors:  Y P Hu; W J Hu; W C Zheng; J X Li; D S Dai; X M Wang; S Z Zhang; H Y Yu; W Sun; G R Hao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies.

Authors:  Bingfu Jiang; Kiyoshi Himmelsbach; Huimei Ren; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

5.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 6.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

7.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

Authors:  T M Hagen; S Huang; J Curnutte; P Fowler; V Martinez; C M Wehr; B N Ames; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.